Commercialization Working Group

The ATMP Sweden Industry Working Group is established to bring together professionals from the ATMP sector with a shared interest in advancing market access and the successful commercialisation of advanced therapy medicinal products in Sweden and the broader Nordic and European markets.

The working group serves as a dedicated forum for exchanging knowledge, identifying common challenges, and developing shared positions on issues related to health technology assessment, pricing and reimbursement, payer engagement, and the strategic and operational aspects of bringing ATMPs to market.

Membership is primarily directed at members active in industry; however, other stakeholders in ATMP Sweden with a relevant professional interest are equally welcome to participate.